Table 1 Patient characteristics of the Main Cohort by (A) graft type, and (B) three time periods.

From: Real-world graft utilization after CTN-1101: a registry-based analysis of haploidentical graft versus umbilical cord blood trends

 

Overall

Haplo

UCB

(A)

N

11,190

8215

2975

Age: median [IQR]

53.7 [38.3, 62.6]

55.3 [40.4, 63.4]

48.6 [33.9, 59.6]

Male: N (%)

6443 (57.6)

4864 (59.2)

1579 (53.1)

Race and Ethnicity: N (%)

 

 Non-Hispanic White

6111 (54.6)

4424 (53.9)

1687 (56.7)

 Black

1797 (16.1)

1425 (17.3)

372 (12.5)

 Hispanic

1944 (17.4)

1433 (17.4)

511 (17.2)

 Asian

705 (6.3)

478 (5.8)

227 (7.6)

 Other or unknown

633 (5.7)

455 (5.5)

178 (6.0)

Disease: N (%)

 

 Acute leukemia

7381 (66.0)

5185 (63.1)

2196 (73.8)

 Chronic leukemia

678 (6.1)

509 (6.2)

169 (5.7)

 MDS

1619 (14.5)

1267 (15.4)

352 (11.8)

 NHL

979 (8.7)

777 (9.5)

202 (6.8)

 HD

134 (1.2)

119 (1.4)

15 (0.5)

 MPN

399 (3.6)

358 (4.4)

41 (1.4)

 

2010–2012

2013–2018

2019–2022

(B)

N

1434

4915

4841

Graft type, N (%)

 

Haplo

459 (32.0)

3363 (68.4)

4393 (90.7)

 2010

126

  

 2011

153

  

 2012

180

  

 2013

 

241

 

 2014

 

309

 

 2015

 

493

 

 2016

 

618

 

 2017

 

770

 

 2018

 

932

 

 2019

  

1033

 2020

  

1138

 2021

  

1192

 2022

  

1030

UCB

975 (68.0)

1552 (31.6)

448 (9.3)

 2010

303

  

 2011

343

  

 2012

329

  

 2013

 

339

 

 2014

 

310

 

 2015

 

276

 

 2016

 

234

 

 2017

 

206

 

 2018

 

187

 

 2019

  

176

 2020

  

104

 2021

  

86

 2022

  

82

Age, median [IQR]

49.7 [35.1, 59.5]

53.5 [38.5, 62.4]

55.1 [39.6, 63.5]

Male, N (%)

820 (57.2)

2787 (56.7)

2836 (58.6)

Race and Ethnicity, N (%)

 

 Non-Hispanic White

859 (59.9)

2774 (56.4)

2478 (51.2)

 Black

243 (16.9)

790 (16.1)

764 (15.8)

 Hispanic

195 (13.6)

773 (15.7)

976 (20.2)

 Asian

84 (5.9)

294 (6.0)

327 (6.8)

 Other or unknown

53 (3.7)

284 (5.8)

296 (6.1)

Disease, N (%)

 

 Acute leukemia

954 (66.5)

3307 (67.3)

3120 (64.4)

 Chronic leukemia

141 (9.8)

309 (6.3)

228 (4.7)

 MDS

141 (9.8)

692 (14.1)

786 (16.2)

 NHL

161 (11.2)

415 (8.4)

403 (8.3)

 HD

18 (1.3)

56 (1.1)

60 (1.2)

 MPN

19 (1.3)

136 (2.8)

244 (5.0)

  1. Haplo haploidentical grafts, UCB umbilical cord blood, IQR interquartile range, MDS myelodysplastic syndrome, NHL non-Hodgkin lymphoma, HD Hodgkin disease/lymphoma, MPN myeloproliferative neoplasm.